摘要
目的探索顽固性心力衰竭患者采用左西孟旦治疗的临床效果。方法顽固性心力衰竭患者34例,按用药方式的不同分为治疗组和对照组,每组17例。对照组患者给予常规治疗,治疗组患者在对照组的基础上加用左西孟旦治疗,观察两组患者的临床效果和不良反应情况。结果治疗组患者的血压和呼吸困难程度评分情况显著优于对照组,治疗组患者的临床射血分数和钾离子情况显著优于对照组,差异有统计学意义(P<0.05)。结论顽固性心力衰竭患者加用左西孟旦治疗,有效的改善了患者的临床症状,明确了用药后产生的不良反应为室性过早博动和低血钾。
Objective To explore the clinical effect of levosimendan in the treatment ot patmnts with refractory heart failure. Methods A total of 34 cases meeting the standard in our hospital were divided into treatment group and control group according to different drug use, and each group contained 17 cases. The control group was given conventional treatment, and the treatment group received levosimendan in addition. The clinical effect and ad~/erse reactions were observed. Results The scores of blood pressure and degree of dyspnea were all better than the control group. The clinical ejection fraction and potassium ion of the observation group were better than the control group. The differences had statistical significance （P〈0.05）. Conclusion Levosimendan treatment for patients with refractory heart failure can effectively improve the clinical symptoms, and its adverse reactions after treatment are ventricular premature beats and hypokalemia.
出处
《中国实用医药》
2014年第25期32-33,共2页
China Practical Medicine
关键词
左西孟旦
顽固性心力衰竭
临床效果
Levosimendan
Refractory heart failure
Clinical effect
